B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 3, 2007, Pages 262-267

  Karaca, Ilgin ^a   Gülcü, Erden ^a   Yavuzkir, Mustafa ^a,b   Daǧli, Necati ^a   Ilkay, Erdoǧan ^a   Özbay, Yilmaz ^a   Işik, Ahmet ^a   Arslan, Nadi ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

B type natriuretic peptide; Diastolic dysfunction; Hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; DISEASE CLASSIFICATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE FILLING; HUMAN; MALE; PATIENT SELECTION; PREDICTION; PROGNOSIS; PULMONARY VEIN; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34648817196     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Dougherty AH, Naccarelli GV, Gray AL, Hicks CH, Goldstain RH. Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-82.
2. Dodek A, Kassebaum DG, Bristow JD. Pulmonary edema in coronary artery disease without cardiomegaly: paradox of stiff heart. N Eng J Med 1972; 286: 1347-50.
3. Maeda K, Tsutamota T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-32.
4. Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretary granules of human cardiac myocytes. Am J Hypertens 1991; 4: 909-12.
5. Tonolo G, Richards AM, Manunta P, Troffa C, Pazzola A, Madeddu P. Low dose infusion of atrial natriuretic factor in mild essential hypertension. Circulation 1989; 80: 893-902.
6. Maisel A. B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure. J Card Fail 2001; 7: 183-93.
7. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349-53.
8. McDenagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al, Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
9. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high-risk community populations. Br Med J 2002; 324: 1498-500.
10. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol 2001; 37: 379-85.
11. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic function. The Framingham heart study. JAMA 2002; 288: 1252-9.
12. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-8.
13. Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Cloptor P, Gardetto N, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction, Am Heart J 2001; 141: 367-74.
14. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-94.
15. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92: 29-34.
16. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257-65.
17. Nishikimi T, Yoshihara F, Morirnoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
18. Suzuki M, Yamamoto K, Watanabe S, Iwata T. Increase of plasma brain natriuretic peptide precedes the cardiac remodeling in primary elderly hypertensive patients. J Am Coll Cardiol 1998; 47: 343A.
19. Rogers EW, Feigenbaum H, Weyman AE. Echocardiography for quantification of cardiac chambers. In: Yu PN, Goodwin JF, editors. Progress in Cardiology. Vol. 8. Philadelphia: Lea and Febiger; 1979. p.807-10.
20. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19: 990-1003.
21. Konecke LL, Feigenbaum H, Chang S, Corya BC, Fischer JC. Abnormal mitral valve motion in patients with elevated left ventricular diastolic pressures. Circulation 1973; 47: 989-96.
22. Ambrose JA, Teichholz LE, Meller J, Weintraub W, Pichard AD, Smith H, et al. The influence of left ventricular late diastolic filling on the A wave of the left ventricular pressure trace. Circulation 1979; 60: 510-9.
23. Spirito P, Maron BJ, Bonow RO. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic techniques. J Am Coll Cardiol 1986; 7: 518-26.
24. Rokey R, Kuo LC, Zoghbi WA, Limacher MC, Quinonens MA. Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation. 1985; 71: 543.
25. Phillips RA, Coplan NL, Krakoff LR, Yeager K, Ross RS, Gorlin R, et al. Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol 1987; 9: 317-22.
26. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
27. Devereux RB, De Simone G, Schlussel CY. Echocardiographic left ventricular mass predicts risk of developing subsequent borderline hypertension. Am Coll Cardiol 1990; 15: 210-8.
28. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with chronic heart failure. Circulation 1993; 87: 464-9.
29. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
30. Luchi RJ, Snow E, Luchi JM, Nelson CL, Pircher FJ. Left ventricular function in geriatric patients. Jam Geriatr Soc 1982; 30: 700-5.
31. Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989; 63: 1526-8.
32. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-74.
33. Bonow R, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med 1992; 117: 502-10.
34. Cregler LL, Georgiou D, Sosa I. Left ventricular diastolic dysfunction in patients with congestive heart failure. J Natl Med Assoc 1991; 83: 49-52.
35. Wei T, Zeng C, Chen L, Chen Q, Zhao R, Lu G, et al. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 2005; 7: 75-9.
36. Suzuki M, Yamamoto K, Watanabe S, Iwata T, Hamada M, Hiwada K. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension. Am J Med 2000; 108: 627-33.
37. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
38. Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure: higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996; 17: 1694-702.
39. Mizuno Y, Yoshimura M, Harada E, Nakayama M, Sakamoto T, Shimasaki Y, et al. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 86: 1036-40.
40. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725-32.
41. Takemura G, Takatsu Y, Doyama K, Itoh H, Saito Y, Koshiji M, et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 1998; 31: 754-65.
42. Nakamura M, Tanaka F, Yonezawa S, Satou K, Nagano M, Hiramori K. The Limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients. Am J Hypertens 2003; 16: 1025-9.
43. Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55-60.
44. Appleton CP, Hatle LK. The natural history of left ventricular filling abnormalities: assessment of two -dimensional and Doppler echocardiography. Echocardiography 1992; 9: 437-57.
45. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92: 1933-9.
46. Appleton CP, Hatle LK, Popp RL. Relation of transmittal flow velocity patterns to left ventricular function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12: 426-40.
47. Rodecki PV, Klein AL. Pitfalls in the echo-Doppler assessment of diastolic dysfunction. Echocardiography 1993; 10: 213-34.